App boosts heart Patients' Pill-Taking in new study
NCT ID NCT05557123
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a smartphone app that reminds patients to take their medication can improve how consistently people with atrial fibrillation take their blood thinner (rivaroxaban). Over 600 adults with AF and other health issues like high blood pressure or diabetes used either the app or standard care for 24 weeks. The main goal was to see if the app helped more patients take at least 95% of their prescribed doses.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Bundang Hospital
Seongnam, 13620, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Could a new injection tame atrial fibrillation?
- Which blood thinner is safer for heart patients? a Head-to-Head test
- Can a cholesterol drug keep atrial fibrillation at bay after ablation?
- Can a One-Two punch fix a leaky heart valve and restore normal rhythm?
- Could a guided Self-Care plan tame atrial Fibrillation's return?